Clip
The Low Toxicity Profile of Psilocybin
30:53 - 33:12 (02:19)
Psilocybin has a remarkably low toxicity profile with no known lethal overdose or damage to organs. There is also no potential mechanism for neurotoxicity.
Similar Clips
The podcast features a discussion about the studies that have been done on psychedelics for treating addiction, anxiety, depression, and end-of-life care.
42:02 - 43:36 (01:34)
Summary
The podcast features a discussion about the studies that have been done on psychedelics for treating addiction, anxiety, depression, and end-of-life care. The guest talks about the surprising results of some of these studies, including one from 2006 by Johns Hopkins.
ChapterThe Surprising Benefits of Psychedelic Drugs
Episode#313: Michael Pollan — Exploring The New Science of Psychedelics
PodcastThe Tim Ferriss Show
Dr. Stephen Ross discusses the potential therapeutic uses of psilocybin, including depression and anxiety associated with a cancer diagnosis, smoking cessation, and alcoholism.
57:24 - 59:09 (01:45)
Summary
Dr. Stephen Ross discusses the potential therapeutic uses of psilocybin, including depression and anxiety associated with a cancer diagnosis, smoking cessation, and alcoholism. Though promising results have been seen in pilot studies, large randomized trials are needed for FDA approval.
ChapterThe Schedule One Category and Marijuana Legalization
Episode#377: Psychedelics — Microdosing, Mind-Enhancing Methods, and More
PodcastThe Tim Ferriss Show
Studies suggest that kava, a natural supplement derived from Pacific island cultures, produces a potent anxiolytic effect and reduces symptoms of anxiety and depression.
2:04:45 - 2:10:38 (05:52)
Summary
Studies suggest that kava, a natural supplement derived from Pacific island cultures, produces a potent anxiolytic effect and reduces symptoms of anxiety and depression.
ChapterThe Efficacy of Saffron and Kava on Anxiety, Stress, PTSD, and Fear
EpisodeErasing Fears & Traumas Based on the Modern Neuroscience of Fear
PodcastHuberman Lab
Dr. D'Amanda Kennedy explains how to start healing anxiety through guided therapeutic experiences with ketamine, MDMA, or psilocybin which can help to reconnect and repair the original cause of anxiety.
23:29 - 26:57 (03:28)
Summary
Dr. D'Amanda Kennedy explains how to start healing anxiety through guided therapeutic experiences with ketamine, MDMA, or psilocybin which can help to reconnect and repair the original cause of anxiety. She also discusses a series of simple steps and coping mechanisms to deal with anxiety like therapy, breath work, meditation, exercise, etc.
ChapterCoping with anxiety through inner work
EpisodeThe Toolkit for Healing Anxiety, Part 1
PodcastThe Mel Robbins Podcast
The proportion of CBD to THC is more linked to the cause or treatment of psychosis, rather than the use of cannabis itself.
2:08:32 - 2:11:29 (02:57)
Summary
The proportion of CBD to THC is more linked to the cause or treatment of psychosis, rather than the use of cannabis itself. Clinical trials for a seizure disorder called Dravet's Syndrome, which causes seizures in children, are currently being conducted.